انتيفيو 300مجم فيال

indications: entyvio (vedolizumab) is indicated for adult patients with moderately to severely active ulcerative colitis (uc) or crohns disease (cd) who have had an inadequate response with were intolerant to or demonstrated dependence on corticosteroids